Next Science
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WANext Science Limited (NXS) is a medical technology with a research and development centre in Florida, USA. NXS has four FDA cleared products currently available in the US market to treat and manage surgical site infections and chronic wounds.
Contact Details
Suite 1902, Level 19, Tower A The Zenith Building, 821 Pacific Hwy, CHATSWOOD NSW 2067
02 8607 5124
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Next Science | $32.6m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1570th | Next Science | -57% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Marc Zimmerman, | 02 Apr 2024 |
| NEW ROLE: Dustin Haines, | 25 Aug 2021 |
| NEW ROLE: Jacqueline Butler, Group Chief Financial Officer, Global | 24 Nov 2020 |
| NEW ROLE: Jon Swanson, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Byron Darroch, Executive VP, Global | 24 Nov 2020 |
| NEW ROLE: Matthew Myntti, President | 24 Nov 2020 |
| REMUNERATION UPDATE: Judith Mitchell, Managing Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Mark Compton, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Gillian Nairn, Company Secretary | 03 Nov 2020 |
